Corrected QT Interval (QTc) Calculator
Accurately calculate QTc using Bazett, Fridericia, or Framingham formulas with our medical-grade calculator
Enter either RR interval OR heart rate (calculator will use RR interval if both provided)
Introduction & Importance of Corrected QT Interval
The corrected QT interval (QTc) is a vital electrocardiographic measurement that assesses ventricular repolarization time while accounting for heart rate variability. This correction is essential because the QT interval naturally shortens at faster heart rates and lengthens at slower rates. Without correction, raw QT measurements would be clinically meaningless for comparison across different heart rates.
QTc prolongation (>450 ms in males, >460 ms in females) serves as a critical biomarker for:
- Drug-induced arrhythmias – Over 100 medications can prolong QT interval, including common antibiotics (macrolides), antipsychotics, and antiarrhythmics
- Congential long QT syndrome – Genetic channelopathies affecting potassium/sodium channels (LQT1-LQT15 subtypes)
- Electrolyte imbalances – Particularly hypokalemia, hypomagnesemia, and hypocalcemia
- Structural heart disease – Hypertrophic cardiomyopathy, myocardial infarction, and heart failure
- Sudden cardiac death risk – QTc >500 ms confers 2-3× increased risk of torsades de pointes
Clinical guidelines from the American College of Cardiology and European Society of Cardiology mandate QTc assessment before initiating QT-prolonging medications and during therapy monitoring. The FDA requires thorough QT studies for all new drug applications.
How to Use This Calculator
- Measure QT interval: From ECG, measure from Q wave onset to T wave end in milliseconds (lead II or V5 typically provides clearest measurement)
- Determine RR interval: Measure distance between two consecutive R waves in milliseconds, or enter heart rate in bpm
- Select correction formula:
- Bazett: QTc = QT/√RR (most widely used but overcorrects at extreme heart rates)
- Fridericia: QTc = QT/³√RR (better for tachycardia, undercorrects at slow rates)
- Framingham: QTc = QT + 0.154(1-RR) (linear correction, best for heart rates 50-120 bpm)
- Specify biological sex: Female sex is associated with 10-15 ms longer baseline QTc
- Review results: Compare against normal ranges (≤450 ms male, ≤460 ms female) and clinical thresholds
- Analyze visualization: The chart shows your QTc relative to normal/abnormal ranges
Formula & Methodology
1. Bazett Formula (1920)
Most commonly used correction due to its simplicity:
QTcB = QT / √(RR)
Where RR interval is in seconds (divide ms by 1000)
Limitations:
- Overcorrects at heart rates >100 bpm (underestimates true QTc)
- Undercorrects at heart rates <60 bpm (overestimates true QTc)
- Poor performance in atrial fibrillation (irregular RR intervals)
2. Fridericia Formula (1920)
Cube root correction provides better accuracy at extreme heart rates:
QTcF = QT / ³√(RR)
Equivalent to QT / (RR)^(1/3)
Advantages:
- More accurate than Bazett at heart rates >100 bpm
- Recommended by 2009 AHA/ACCF/HRS scientific statement for drug studies
- Better correlation with cardiac events in population studies
3. Framingham Formula (1992)
Linear correction developed from Framingham Heart Study data:
QTcFR = QT + 0.154(1 – RR)
Where RR interval is in seconds
Characteristics:
- Most accurate for heart rates between 50-120 bpm
- Less sensitive to RR interval measurement errors
- Preferred in epidemiological studies
Sex-Specific Normal Ranges
| Parameter | Male | Female | Clinical Significance |
|---|---|---|---|
| Upper limit of normal | ≤450 ms | ≤460 ms | Values above indicate prolonged repolarization |
| Borderline prolonged | 451-470 ms | 461-480 ms | Warrants monitoring but not acute intervention |
| Prolonged | 471-499 ms | 481-500 ms | Increased torsades risk; consider drug adjustment |
| Severely prolonged | ≥500 ms | ≥500 ms | High torsades risk; requires immediate evaluation |
Real-World Examples
Case Study 1: Drug-Induced QT Prolongation
Patient: 68-year-old female with pneumonia started on moxifloxacin 400 mg daily
Baseline ECG:
- QT interval: 380 ms
- RR interval: 800 ms (75 bpm)
- QTc (Bazett): 425 ms
Day 3 ECG:
- QT interval: 440 ms
- RR interval: 833 ms (72 bpm)
- QTc (Bazett): 488 ms (↑63 ms from baseline)
Action: Moxifloxacin discontinued; QTc normalized to 430 ms after 48 hours. This demonstrates:
- Importance of baseline QTc measurement
- Need for serial monitoring on QT-prolonging drugs
- Reversibility of drug-induced QTc prolongation
Case Study 2: Congenital Long QT Syndrome
Patient: 14-year-old male with syncope during swimming
ECG Findings:
- QT interval: 460 ms
- RR interval: 1000 ms (60 bpm)
- QTc (Bazett): 460 ms
- QTc (Fridericia): 440 ms
- Notched T waves in V2-V4
Genetic Testing: Positive for KCNQ1 mutation (LQT1)
Management:
- Beta-blocker therapy (propranolol 80 mg BID)
- Avoidance of QT-prolonging drugs
- Family screening (mother found to have QTc 470 ms)
- ICD placement considered but deferred due to good beta-blocker response
Case Study 3: Electrolyte-Induced QT Prolongation
Patient: 72-year-old male with chronic diarrhea on furosemide 80 mg daily
Presentation:
- Fatigue and palpitations
- Serum potassium: 2.8 mEq/L
- Serum magnesium: 1.4 mg/dL
ECG:
- QT interval: 520 ms
- RR interval: 1200 ms (50 bpm)
- QTc (Bazett): 505 ms
- Prominent U waves
Intervention:
- IV potassium chloride 40 mEq over 2 hours
- IV magnesium sulfate 2g over 15 minutes
- Holding furosemide
- Repeat ECG after 6 hours showed QTc 440 ms
Data & Statistics
Comparison of QTc Formulas in Different Heart Rate Ranges
| Heart Rate (bpm) | Actual QT (ms) | Bazett QTc (ms) | Fridericia QTc (ms) | Framingham QTc (ms) | % Difference from Fridericia |
|---|---|---|---|---|---|
| 50 | 400 | 447 | 428 | 420 | Bazett: +4.4% |
| 70 | 380 | 420 | 410 | 408 | Bazett: +2.4% |
| 90 | 350 | 408 | 392 | 395 | Bazett: +4.1% |
| 110 | 320 | 395 | 368 | 375 | Bazett: +7.3% |
| 130 | 300 | 387 | 350 | 360 | Bazett: +10.6% |
Data adapted from Vandenberk et al. (2012) showing Bazett’s overcorrection at higher heart rates. Fridericia provides more consistent values across heart rate spectrum.
QTc Prolongation Prevalence by Condition
| Clinical Condition | Prevalence of QTc >450 ms | Mean QTc (ms) | Relative Risk of SCD | Source |
|---|---|---|---|---|
| Healthy adults | 2-5% | 400-420 | 1.0 (reference) | Framingham Heart Study |
| Heart failure (NYHA III-IV) | 25-30% | 460-480 | 2.5-3.0 | JAMA 2003 |
| Acute myocardial infarction | 15-20% | 450-470 | 1.8-2.2 | GISSI-2 Study |
| Congenital LQTS | 100% | 480-520 | 10-20 | Circulation 2013 |
| Hypokalemia (K+ <3.0 mEq/L) | 40-50% | 470-500 | 3.0-4.0 | NEJM 1998 |
| Drug-induced (class IA/III antiarrhythmics) | 30-40% | 460-490 | 2.0-3.5 | FDA QT Study Guidelines |
Expert Tips for Accurate QTc Assessment
Measurement Techniques
- Lead selection:
- Use lead II or V5/V6 for most accurate QT measurement
- Avoid leads with poor T wave definition (V1, aVR)
- In U wave presence, measure to T wave nadir before U wave
- Beat selection:
- Average 3-5 consecutive beats
- Avoid post-ectopic beats (compensatory pause affects QT)
- In atrial fibrillation, measure 5-10 beats and average
- Heart rate correction:
- Always report which formula was used
- For heart rates <50 or >100 bpm, use Fridericia
- For drug studies, FDA recommends Fridericia
Clinical Interpretation Pearls
- Borderline QTc (450-470 ms):
- Repeat measurement in 24-48 hours
- Check electrolytes (K+, Mg++, Ca++)
- Review medication list for QT-prolonging drugs
- QTc 470-500 ms:
- Hold non-essential QT-prolonging medications
- Correct electrolytes if abnormal
- Consider cardiac monitoring if symptomatic
- QTc >500 ms:
- Emergent cardiology consultation
- Continuous telemetry monitoring
- Consider IV magnesium if torsades risk factors
- Temporary pacing if pause-dependent
Common Pitfalls to Avoid
- Using uncorrected QT – Raw QT values are meaningless without heart rate correction
- Ignoring U waves – May falsely lengthen apparent QT interval
- Single-lead measurement – Always confirm in multiple leads
- Assuming normalcy – “Normal” QTc in females is 10 ms longer than males
- Overlooking intraventricular conduction delay – QRS >120 ms requires adjusted QTc calculation
- Disregarding clinical context – QTc must be interpreted with symptoms and risk factors
Interactive FAQ
Why do we need to correct the QT interval for heart rate?
The QT interval shortens at faster heart rates and lengthens at slower rates due to physiological adaptation. Without correction, you couldn’t compare QT intervals across different heart rates. For example:
- At 60 bpm, a normal QT might be 400 ms
- At 120 bpm, a normal QT might be 300 ms
- Correction allows meaningful comparison (both would be ~400 ms QTc)
This correction is based on the observation that ventricular repolarization time (QT) is inversely proportional to the square root (Bazett) or cube root (Fridericia) of the cardiac cycle length (RR interval).
Which QTc correction formula is most accurate?
The “best” formula depends on the clinical context:
| Scenario | Recommended Formula | Rationale |
|---|---|---|
| General clinical use | Bazett | Most familiar to clinicians; good for heart rates 60-100 bpm |
| Tachycardia (>100 bpm) | Fridericia | Less overcorrection than Bazett at fast rates |
| Bradycardia (<60 bpm) | Framingham | Linear correction performs better at slow rates |
| Drug development studies | Fridericia | FDA recommendation; better correlation with torsades risk |
| Pediatric patients | Bazett or Fridericia | Both validated in children; Fridericia may be slightly better |
For maximum accuracy, some experts recommend reporting all three formulas when making critical clinical decisions.
How does biological sex affect QTc interpretation?
Biological sex significantly influences QTc intervals:
- Hormonal effects: Estrogen prolongs QT interval by ~10-15 ms compared to testosterone
- Normal ranges:
- Males: ≤450 ms
- Females: ≤460 ms
- Clinical implications:
- Females have 2-3× higher risk of drug-induced torsades de pointes
- Postmenopausal women lose some of this sex difference
- Pregnancy may transiently prolong QTc by 5-10 ms
- Mechanism: Estrogen modulates potassium channel (IKr) expression and function
Always use sex-specific normal ranges when interpreting QTc values. The calculator automatically adjusts thresholds based on the selected biological sex.
What are the limitations of automated QTc measurements?
While modern ECG machines provide automated QTc measurements, they have several limitations:
- Algorithm variability:
- Different manufacturers use proprietary algorithms
- Can vary by up to 30 ms between devices
- T wave detection issues:
- Difficulty with flat or biphasic T waves
- May include U waves in measurement
- Heart rate limitations:
- Poor accuracy with atrial fibrillation
- Overcorrection in tachycardia
- Technical factors:
- Baseline wander can affect measurements
- Muscle artifact may interfere with T wave detection
Expert recommendation: Always manually verify automated QTc measurements, especially when values are borderline or clinical suspicion is high. The AHA recommends manual measurement in:
- Patients with QTc >480 ms
- When evaluating for congenital LQTS
- During QT-prolonging drug therapy
What medications most commonly prolong the QTc interval?
Over 100 medications can prolong QTc. The highest risk categories include:
| Drug Class | Examples | Typical QTc Prolongation | Torsades Risk |
|---|---|---|---|
| Class IA antiarrhythmics | Quinidine, Procainamide, Disopyramide | 30-60 ms | High |
| Class III antiarrhythmics | Amiodarone, Sotalol, Dofetilide | 20-50 ms | Moderate-High |
| Antipsychotics | Haloperidol, Thioridazine, Ziprasidone | 15-40 ms | Moderate |
| Antidepressants | Citalopram (>40 mg), Tricyclics | 10-30 ms | Low-Moderate |
| Antibiotics | Moxifloxacin, Erythromycin, Clarithromycin | 10-25 ms | Low-Moderate |
| Antifungals | Fluconazole, Ketoconazole | 5-20 ms | Low |
| Antiemetics | Ondansetron, Dolasetron | 5-15 ms | Low |
Always check CredibleMeds.org for updated lists of QT-prolonging medications and their risk categories. Remember that:
- Risk is dose-dependent (e.g., citalopram >40 mg/day)
- Polypharmacy increases risk synergistically
- Electrolyte abnormalities amplify drug effects
How should QTc be monitored during hospitalization?
Hospitalized patients require systematic QTc monitoring when receiving QT-prolonging medications or with risk factors:
Monitoring Protocol:
- Baseline ECG:
- Obtain within 1 hour of admission
- Measure QTc using multiple formulas
- Document all medications and electrolytes
- High-risk patients (daily ECG):
- Baseline QTc >450 ms
- Receiving class IA/III antiarrhythmics
- Severe electrolyte abnormalities
- Congestive heart failure (EF <30%)
- Moderate-risk patients (ECG every 48-72 hours):
- Baseline QTc 430-450 ms
- Receiving moderate-risk QT drugs
- Mild-moderate electrolyte abnormalities
- Electrolyte management:
- Maintain K+ >4.0 mEq/L
- Maintain Mg++ >1.8 mg/dL
- Correct hypocalcemia if present
- Drug adjustments:
- Hold QT-prolonging drugs if QTc >500 ms
- Reduce dose if QTc increases >60 ms from baseline
- Consider alternative agents if QTc >480 ms
Critical thresholds for intervention:
- QTc >500 ms: Immediate cardiology consult
- QTc increase >60 ms from baseline: Re-evaluate therapy
- QTc >550 ms: Consider temporary pacing
What are the ECG findings associated with long QT syndrome?
Long QT syndrome (LQTS) has characteristic ECG findings beyond just QTc prolongation:
Primary ECG Features:
- Prolonged QT interval:
- QTc typically >480 ms in symptomatic patients
- May be intermittent (“concealed LQTS”)
- T wave abnormalities:
- Broad-based T waves (LQT1, LQT2)
- Biphasic T waves (LQT2)
- Late-onset T waves (LQT3)
- T-U wave patterns:
- Prominent U waves (especially in LQT2)
- T-U wave fusion creating “double hump”
- Bradycardia:
- Relative bradycardia common in LQT1 and LQT2
- May see sinus pauses or AV block
Genotype-Phenotype Correlations:
| LQTS Type | Gene | ECG Characteristics | Triggers |
|---|---|---|---|
| LQT1 | KCNQ1 | Broad T waves, prolonged ST segment | Exercise, swimming, emotional stress |
| LQT2 | KCNH2 | Low-amplitude, biphasic T waves | Auditory stimuli, postpartum period |
| LQT3 | SCN5A | Late-onset T wave, long isoelectric ST | Sleep, bradycardia |
| LQT4-15 | Various | Often nonspecific QTc prolongation | Variable by subtype |
Diagnostic criteria: Use the Schwartz score which incorporates:
- QTc duration (scored by severity)
- T wave morphology
- Clinical history (syncope, family history)
- Genetic testing results